Synthomer (LON:SYNT - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported GBX (3.50) (($0.05)) earnings per share for the quarter, Digital Look Earnings reports. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%.
Synthomer Stock Down 8.3 %
Shares of SYNT stock traded down GBX 10.40 ($0.13) during trading on Thursday, hitting GBX 114.40 ($1.48). 1,828,885 shares of the company were exchanged, compared to its average volume of 640,897. The business's 50-day simple moving average is GBX 139.90 and its 200 day simple moving average is GBX 171.16. Synthomer has a twelve month low of GBX 114 ($1.48) and a twelve month high of GBX 338 ($4.38). The firm has a market capitalization of £187.59 million, a price-to-earnings ratio of -2.29, a P/E/G ratio of -0.17 and a beta of 1.79. The company has a debt-to-equity ratio of 78.27, a quick ratio of 0.97 and a current ratio of 1.90.
Wall Street Analyst Weigh In
Separately, Berenberg Bank cut their price target on shares of Synthomer from GBX 265 ($3.43) to GBX 230 ($2.98) and set a "buy" rating on the stock in a report on Monday, January 6th.
Check Out Our Latest Analysis on SYNT
Synthomer Company Profile
(
Get Free Report)
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Read More
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.